The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity
- PMID: 1381311
- DOI: 10.1002/eji.1830220915
The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity
Abstract
This study addressed the question of whether the mucosal adjuvant property of cholera toxin (CT) and the structurally closely related Escherichia coli heat-labile toxin (LT) requires the enterotoxic and adenylate cyclase/cAMP activating property of these molecules. Therefore, we investigated the cytotoxic and adjuvant abilities of the enterotoxins and compared the results with those obtained with the non-toxic CT and LT derivatives; recombinant CTB (rCTB) and a mutated LT (mLT), which had a single amino acid substitution in position 112 (Glu----Lys) of the A subunit. Detailed functional studies revealed that, in contrast to the enterotoxins, both rCTB and mLT lacked ADP-ribosylating and cAMP-stimulating abilities. However, similar membrane ganglioside GM1-receptor binding ability of all the putative adjuvants was demonstrated. When the probe antigen, keyhole limpet hemocyanin (KLH), was given perorally together with CT or LT strong gut mucosal anti-KLH immune responses were stimulated, whereas no or very low anti-KLH responses were seen in the groups which received antigen admixed with rCTB or the mLT. Moreover, the specific serum antibody responses to the various immunization protocols closely paralleled the local anti-KLH response in the gut. From these results it appears that the adjuvant mechanism of LT, and probably also of CT, is linked to the ability to ADP-ribosylate and to stimulate cAMP formation. However, this study does not unequivocally rule out other possibilities such as interactions by the A1 fragment of CT or LT with other G-proteins than Gs alpha or events that parallel or precede the effects on the adenylate cyclase/cAMP system. Thus, the levels of ADP-ribosylation and cAMP-induction that are required and the key event or target cell that is responsible for the adjuvant effect of CT and LT remain to be elucidated. Studies are underway to address these issues.
Similar articles
-
Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant.Infect Immun. 2004 May;72(5):2827-36. doi: 10.1128/IAI.72.5.2827-2836.2004. Infect Immun. 2004. PMID: 15102793 Free PMC article.
-
Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin.Eur J Immunol. 1998 Apr;28(4):1243-50. doi: 10.1002/(SICI)1521-4141(199804)28:04<1243::AID-IMMU1243>3.0.CO;2-E. Eur J Immunol. 1998. PMID: 9565364
-
Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.Infect Immun. 2000 Jan;68(1):281-7. doi: 10.1128/IAI.68.1.281-287.2000. Infect Immun. 2000. PMID: 10603399 Free PMC article.
-
The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.Immunol Cell Biol. 1998 Jun;76(3):270-9. doi: 10.1046/j.1440-1711.1998.00745.x. Immunol Cell Biol. 1998. PMID: 9682971 Review.
-
ADP-ribosylating enterotoxins as vaccine adjuvants.Curr Opin Pharmacol. 2018 Aug;41:42-51. doi: 10.1016/j.coph.2018.03.015. Epub 2018 May 22. Curr Opin Pharmacol. 2018. PMID: 29702466 Review.
Cited by
-
Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.Clin Exp Immunol. 2000 Aug;121(2):283-8. doi: 10.1046/j.1365-2249.2000.01282.x. Clin Exp Immunol. 2000. PMID: 10931143 Free PMC article.
-
Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun.Clin Vaccine Immunol. 2011 Jun;18(6):922-30. doi: 10.1128/CVI.05019-11. Epub 2011 Apr 20. Clin Vaccine Immunol. 2011. PMID: 21508173 Free PMC article.
-
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.Infect Immun. 1995 Jun;63(6):2100-8. doi: 10.1128/iai.63.6.2100-2108.1995. Infect Immun. 1995. PMID: 7768587 Free PMC article.
-
Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells.Infect Immun. 2007 Jun;75(6):3150-9. doi: 10.1128/IAI.00581-06. Epub 2007 Mar 12. Infect Immun. 2007. PMID: 17353279 Free PMC article.
-
Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.Infect Immun. 2005 Jul;73(7):4088-97. doi: 10.1128/IAI.73.7.4088-4097.2005. Infect Immun. 2005. PMID: 15972497 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources